Use of circulating tumour cells as a prognostic or predictive marker
20 Oct 2011
Use of circulating tumour cells as a prognostic or predictive marker
60 years in oncology
Roundup of the EMCC 2011 conference
Olaparib extends PFS in women with high-grade serous ovarian cancer
Genetic basis of cancer predisposition
4HBR chemoprevention in BRCA positive women
Genetic mutations as causes of cancer
ecancerhub past, present and future
Early detection and prevention of melanoma (6/6)
Personalised medicine and cancer control in India
The P-Medicine project; data sharing and integration for personalised medicine
Association of diabetes and cancer epidemiology